Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Acquisitions Trending in Dermatological Drugs Market

November 18, 2015 11:13 am | News | Comments

LEO Pharma's acquisition of the global dermatology business of Astellas Pharma for almost $725 million confirms Kalorama Information's projection that the worldwide pharmaceutical sector will only expand through mergers and acquisitions for some time to come. Read more...


HIV Could Be Flushed Out of Hiding by Alcoholism Drug Disulfiram

November 18, 2015 11:03 am | by Seth Augenstein, Digital Reporter | News | Comments

HIV can be beaten back by a growing wealth of effective drugs. But it has proven to be a tough survivor, finding a way to hide in patients’ tissue from the attempts to eradicate it. But a drug typically used to treat alcoholism could be the “game changer” to flush it out, according to a group of international researchers. Read more...


Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus

November 18, 2015 10:57 am | News | Comments

Pharmaceutical industry veterans Don DeGolyer and Andrew Saik today announced that they have launched Vertice Pharma, LLC ("Vertice Pharma" or "the Company") in partnership with Warburg Pincus, a global private equity firm focused on growth investing. Read more..


Senate Panel Questions FDA Nominee on Drug Prices, Approvals

November 18, 2015 10:47 am | by Mary Clare Jalonick, Associated Press | News | Comments

President Barack Obama's nominee to lead the Food and Drug Administration defended his record Tuesday as senators pressed him about rising drug prices, slow approval times for new drugs and his ties to the pharmaceutical industry. Read more...


Working with Reference Laboratories to Support CDx Commercialization

November 18, 2015 8:59 am | by Brian Baranick and Alex Vadas, L.E.K. Managing Directors in Life Sciences and Biopharmaceutical practice | Articles | Comments

Companion diagnostic (CDx) tests are vital to personalized medicine, but the commercialization of these tests increases challenges for biopharmaceutical companies, whose main objective is to ensure patients’ unconstrained access to the tests. Read more...


Big Bellies Sign of Worse Health than Normal Obesity

November 18, 2015 8:33 am | by Seth Augenstein, Digital Reporter | News | Comments

Muffin tops, lovehandles, spare tires, paunches, and beer bellies all are a burgeoning health problem, according to new medical findings. A thick waistline, even on people not considered overweight, is a risk showing that it’s not just how much you weight, but also where you store it, according to a new study in the Annals of Internal Medicine. Read more...


$2.8M Boost for Developing Malaria Vaccine

November 18, 2015 8:00 am | by Walter + Eliza Hall Research Institute | News | Comments

The funding will enable the team of researchers from North Queensland and Victoria to develop a broad spectrum vaccine effective against most species of human malaria. Read more...


A New Target for Immuno-OncologyTherapies

November 18, 2015 7:45 am | by Institut de Recherches Clinique de Montreal | News | Comments

The researchers study natural killer (NK) cells, which are crucial to the immune system and protect the body by destroying cancer cells. Read more...


3D-mapping A New Drug Delivery Tool

November 18, 2015 7:30 am | by Ecole Polytechnique Federale De Lausanne | News | Comments

Scientists from EPFL and Nestlé have developed a new method that can “see” inside dispersed cubosomes (dispersed cubic liquid crystalline phases) with unprecedented detail. Read more...


Ringing the Changes 'Opens the Road to New Medicines'

November 18, 2015 7:15 am | by University of York | News | Comments

The molecules contain atoms arranged in large rings, known as macrocycles, whose importance in medicine has been known for decades. Read more...


Three Cups of Coffee a Day Keeps Death Away, Latest Study Shows

November 18, 2015 7:00 am | by Seth Augenstein, Digital Reporter | News | Comments

Moderate coffee drinking reduces mortality rates from a wide variety of diseases, according to the latest study by Harvard researchers. Read more...


Obtuse Language, Muddled Meanings Mark Scientific Fraud

November 17, 2015 4:36 pm | by Seth Augenstein, Digital Reporter | News | Comments

Obfuscated, muddled and willfully difficult jargon are a hallmark of scientific fraud, according to a new analysis of bunk science. Linguistic analysis of hundreds of retracted papers led to a model which could curb the growing phenomenon of retractions and ethical violations, according to the new study, published in the Journal of Language and Social Psychology. Read more...


Portable Brain Scanners, 3-D Models at SfN in Chicago

November 17, 2015 1:00 pm | by Drug Discovery & Development | Videos | Comments

In this one-minute video series, Drug Discovery & Development is highlighting the latest headlines and trends happening within the industry.


Clovis Oncology Shares Plunge over Poor Lung Cancer Response Rates

November 17, 2015 11:16 am | by Ryan Bushey, Associate Editor | News | Comments

The company’s stock plummeted 72 percent on Monday.


AbbVie: Virologic Response Rates in Hepatitis C Phase 2 Studies

November 17, 2015 10:57 am | News | Comments

​AbbVie, a global biopharmaceutical company, today announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, that show high rates of sustained virologic response at 12 weeks post-treatment (SVR12) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.